Breaking News Instant updates and real-time market news.

NOC

Northrop Grumman

$307.77

-0.445 (-0.14%)

, LMT

Lockheed Martin

$328.22

0.21 (0.06%)

17:33
10/19/18
10/19
17:33
10/19/18
17:33

Trump to meet CEOs of Boeing, Lockheed Martin, General Dynamics, Reuters reports

President Donald Trump will meet with CEOs of Lockheed Martin (LMT), Boeing (BA), Northrop Grumman (NOC) and General Dynamics (GD) at Luke Air Force Base in Arizona, according to Reuters, citing people familiar with the matter. The group is meeting, for the second time in the past two weeks, to discuss sourcing more parts and materials in the U.S. Executives from BAE Systems (BAESY) and Honeywell (HON) will also be present at the meeting discussing supply chains. Weapons sales to Saudi Arabia were reportedly not on the agenda for the meeting, but the issue could be raised. Reference Link

NOC

Northrop Grumman

$307.77

-0.445 (-0.14%)

LMT

Lockheed Martin

$328.22

0.21 (0.06%)

BA

Boeing

$356.28

-3 (-0.84%)

GD

General Dynamics

$190.43

-0.76 (-0.40%)

BAESY

BAE Systems

$0.00

(0.00%)

HON

Honeywell

$153.49

-1.73 (-1.11%)

  • 19

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 30

    Oct

NOC Northrop Grumman
$307.77

-0.445 (-0.14%)

09/21/18
09/21/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. UBS SAYS BUY AT&T: UBS analyst John Hodulik upgraded AT&T (T) to Buy and raised his price target for the shares to $38 from $33, noting that the stock is trading near all-time low valuations and at its widest valuation gap to Verizon (VZ). The Time Warner transaction and accounting changes "have compounded [other] issues, leading to a loss of visibility for investors," but his work indicates that AT&T will return to EBITDA growth in the second half of 2018, after a 6% decline in the first half, due to growth in Wireless and WarnerMedia as well as slower declines in Entertainment. JPMORGAN GOES TO BULL FROM BEAR ON NOVAVAX: JPMorgan analyst Eric Joseph double upgraded Novavax (NVAX) to Overweight from Underweight saying the risk/reward is favorable into the report of Prepare trial data in Q1 of 2019. The trial is assessing the efficacy of the company's RSV F Vaccine for infants via maternal immunization and the analyst believes the shares can hit a range of $2.00 to $2.25, he told investors. JPMORGAN SUGGESTS BEING SHORT COPART, LONG KAR: JPMorgan analyst Ryan Brinkman downgraded Copart (CPRT) to Underweight and lowered his price target for the shares to $47 from $48. The company reported softer than expected Q4 results this week but trades at "near record multiples" of earnings and EBITDA, Brinkman told investors. The analyst sees a potential pair trade in going long KAR Auction (KAR) shares, and short Copart shares, to capitalize on the "valuation disconnect." LOOP SETS $8.25 TARGET ON HARMONIC: Loop Capital analyst James Kisner initiated Harmonic (HLIT) with a Buy rating and $8.25 price target, saying he believes Harmonic can "drive robust revenue growth on its Cable Edge business as cable operators like Comcast (CMCSA, CMCSK) adopt its virtual CCAP/CMTS solution," and that the company's video business with stabilize. 'DON'T PANIC' OVER DOD PROPOSAL: Morgan Stanley analyst Rajeev Lalwani attributes the underperformance in Defense stocks over the last two days compared to the broader market to heightened concerns around a month old proposal from the Department of Defense to adjust progress and performance payments down to 50% from 80% of cost, which would effectively slow the timing of cash flow receipts closer to when a project is complete. He sees a number of reasons not to panic, mainly because he believes that the Administration will not move forward with a proposal industry-players will paint as being anti-business and anti-defense spending. Publicly-traded defense contractors include General Dynamics (GD), Huntington Ingalls (HII), L3 Technologies (LLL), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).
09/21/18
MSCO
09/21/18
NO CHANGE
MSCO
Morgan Stanley says not to panic over Defense payment proposal
Morgan Stanley analyst Rajeev Lalwani attributes the underperformance in Defense stocks over the last two days compared to the broader market to heightened concerns around a month old proposal from the Department of Defense to adjust progress and performance payments down to 50% from 80% of cost, which would effectively slow the timing of cash flow receipts closer to when a project is complete. He sees a number of reasons not to panic, firstly because he believes that the Administration will not move forward with a proposal industry-players will paint as being anti-business and anti-defense spending. Even if it were to move forward, the proposal primarily impacts cash flow timing, with underlying earnings unchanged and potential offsets evident, Lalwani tells investors. Lastly, while there would be considerable uncertainty around rule implementation, the proposal would create a path to superior cash flows versus today, the analyst added. Companies in the defense contracting space include General Dynamics (GD), Huntington Ingalls (HII), L3 Technologies (LLL), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).
08/15/18
UBSW
08/15/18
INITIATION
Target $315
UBSW
Neutral
Northrop Grumman initiated with a Neutral at UBS
UBS analyst Myles Walton initiated coverage of the Aerospace & Defense sector, starting Northrop Grumman with a Neutral rating and $315 price target.
07/31/18
07/31/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Neutral from Reduce at Nomura Instinet analyst Mark Kelley saying after selling off 27% since the Q2 earnings report on July 27, expectations have been appropriately reset. 2. Chipotle (CMG) upgraded to Buy from Hold at Jefferies with analyst Andy Barish saying he believes Chipotle is one of the better positioned companies to benefit from the ongoing shift to digital/off-premise. 3. Affiliated Managers (AMG) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Robert Lee saying he believes the company is positioned for "at least" modest organic growth. 4. Booz Allen (BAH) upgraded to Outperform from Market Perform at Raymond James with analyst Brian Gesuale saying the Q1 report was "stellar," beating every key metric, while the share reaction was "lukewarm." 5. Northrop Grumman (NOC) upgraded to Buy on valuation at Buckingham with analyst Richard Safran saying the sell-off following the Q2 report provides an investment opportunity telling investors Defense spending and recent program wins may not be fully reflected in consensus expectations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
LMT Lockheed Martin
$328.22

0.21 (0.06%)

08/15/18
UBSW
08/15/18
INITIATION
Target $400
UBSW
Buy
Lockheed Martin initiated with a Buy at UBS
UBS analyst Myles Walton initiated coverage of the Aerospace & Defense sector, starting Lockheed Martin with a Buy rating and $400 price target.
10/03/18
FBCO
10/03/18
NO CHANGE
Target $368
FBCO
Neutral
Lockheed Martin price target raised to $368 from $340 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Lockheed Martin to $368 from $340 as his in-depth review of both the F-35 program and the broader business suggests that the bear case largely misses the mark. The analyst believes that Aeronautics and MFC will remain Lockheed's growth leaders over the next several years, and expects growth in Aeronautics to slow but remain positive beyond 2020 as rising F-35 sustainment revenues are only partially offset by C-130J headwinds and plateauing F-35 procurement quantities. RMS faces Black Hawk headwinds in the near-term, but growth should pick up in 2020 and beyond, he contends, adding that space should grow modestly in the near-term. The analyst reiterates a Neutral rating on the shares.
BA Boeing
$356.28

-3 (-0.84%)

09/06/18
BARD
09/06/18
NO CHANGE
Target $450
BARD
Outperform
Boeing supply chain stress concerns overblown, says Baird
Baird analyst Peter Arment said Boeing remains his top pick as he believes the anxiety around supply chain stress is overblown. The analyst believes the company is on target to meet its 2018 guidance and 2019 is setting up as a very favorable year in terms of earnings and cash flow improvements. Arment reiterated his Outperform rating and $450 price target on Boeing shares.
09/06/18
JEFF
09/06/18
NO CHANGE
Target $410
JEFF
Buy
Boeing price target raised to $410 from $400 at Jefferies
Jefferies analyst Sheila Kahyaoglu raised her price target for Boeing to $410 after the company hosted analysts and investors at its Everett and Renton facilities. Boeing has been able to drive productivity through improved processes and sharing best practices across programs and business units, Kahyaoglu tells investors in a research note. She believes near-term challenges around 737 and KC-46 "seem manageable" and keeps a Buy rating on the shares.
09/28/18
MSCO
09/28/18
NO CHANGE
Target $400
MSCO
Equal Weight
Morgan Stanley says NMA pivotal to Boeing long-term vision, but a near-term risk
Morgan Stanley analyst Rajeev Lalwani said Boeing's decision to move forward with its New Midsize Aircraft is likely within a year, which may raise the risk profile as clean-sheet designs typically do. Despite the back and forth among analysts on its viability, Lalwani believes the NMA program is likely to move forward as he sees it being pivotal to Boeing's long-term vision for a competitive product offering, expanding Services, and smoothing development cycles. Some type of response from Airbus (EADSY) is probable given the companies' history of "tit-for-tat," added Lalwani, who keeps an Equal Weight rating and $400 price target on Boeing shares.
08/20/18
LEHM
08/20/18
NO CHANGE
LEHM
Airbus catching up as MAX deliveries slow, says Barclays
Barclays analyst David Strauss, tracking deliveries and flight activity on the new narrowbodies including the A320neo (EADSY) and 737 MAX (BA), estimates that Airbus is catching up as MAX deliveries slow, telling investors in a research note that Airbus delivered five A320neos last week and has delivered 316 A320s YTD, or 52% of full year guidance, while Boeing has delivered 311 737s, or 53% of full year guidance.
GD General Dynamics
$190.43

-0.76 (-0.40%)

08/20/18
LOOP
08/20/18
NO CHANGE
Target $210
LOOP
Buy
CACI latest guidance increasingly seen as 'conservative', says Loop Capital
Loop Capital analyst Joseph Vafi keeps his Buy rating and $210 price target on CACI (CACI), but notes that the company's latest guidance is likely to be even more conservative than he previously assumed after it confirmed the acquisition of certain Navy contracts from General Dynamics (GD). Vafi says he will look for any potential 8K filing disclosures from General Dynamics on the size of its Seaport-e business, which had booked those contracts, in 2017, and estimates as much as over $30M in conservatism related to CACI's FY19 revenue outlook.
08/15/18
UBSW
08/15/18
INITIATION
Target $210
UBSW
Neutral
General Dynamics initiated with a Neutral at UBS
UBS analyst Myles Walton initiated coverage of the Aerospace & Defense sector, starting General Dynamics with a Neutral rating and $210 price target.
BAESY BAE Systems
$0.00

(0.00%)

01/10/18
UBSW
01/10/18
UPGRADE
UBSW
Buy
BAE Systems upgraded to Buy from Neutral at UBS
UBS analyst Celine Fornaro upgraded BAE Systems to Buy with an increased price target of 670p. The stock's valuation on a cash flow basis is "undemanding" following the pension deficit review and the confirmation of the Qatar order, the analyst contends.
02/23/18
JPMS
02/23/18
DOWNGRADE
JPMS
Underweight
BAE Systems downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst David Perry downgraded BAE Systems to Underweight and lowered his price target for the shares to 550p from 555p. The company's "lackluster" guidance for 2018 suggests it will continue to underperform its peers in U.S. defense and in European civil aero, Perry tells investors in a research note. He sees BAE's "long-term underperformance" versus peers continuing in 2018.
04/24/18
BREN
04/24/18
UPGRADE
BREN
Buy
BAE Systems upgraded to Buy from Hold at Berenberg
Berenberg analyst Andrew Gollan upgraded BAE Systems to Buy and raised his price target for the shares to 700p from 600p. The current valuation is not reflective of the improved defense market, Gollan tells investors in a research note. He believes the stock's valuation discount to U.S. peers is unwarranted.
06/29/18
JPMS
06/29/18
UPGRADE
JPMS
Neutral
BAE Systems upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst David Perry upgraded BAE Systems to Neutral and raised his price target for the shares to GBP 6.85 from GBP 6.55.
HON Honeywell
$153.49

-1.73 (-1.11%)

10/12/18
FBCO
10/12/18
INITIATION
Target $170
FBCO
Neutral
Honeywell initiated with a Neutral at Credit Suisse
Credit Suisse analyst John Walsh initiated Honeywell with a Neutral rating and $170 price target, telling investors in a research note that he sees "multiple levers" for margin expansion, though the gross margin is still well below peers. Looking ahead, Walsh sees sustained mid-single digit organic growth driven by long-cycle businesses, and expects margin to expand driven by manufacturing and logistics footprint consolidation and connected solutions.
10/12/18
FBCO
10/12/18
INITIATION
FBCO
Outperform
EE, MI Sector initiated with Opportunistic View at Credit Suisse
Credit Suisse analyst John Walsh initiated the U.S. Electrical Equipment and Multi-Industry Sector with an Opportunistic View, telling investors in a research note that he believes at this point in the cycle stock appreciation will be driven by earnings growth and capital allocation. He is most positive on energy-related and non-residential end markets while cautious on Fossil Power markets. Specifically, Walsh initiated Allegion (ALLE), Eaton (ETN), Ingersoll-Rand (IR), Lennox (LII), 3M (MMM) and Xylem (XYL) with Outperform ratings, Acuity Brands (AYI), Emerson (EMR), Flowserve (FLS), Fortiv (FTV), GE (GE), Honeywell (HON) and Johnson Controls (JCI) with Neutral ratings and Rockwell Automation (ROK) with an Underperform rating.
10/12/18
GDHS
10/12/18
INITIATION
Target $175
GDHS
Buy
Honeywell initiated with a Buy at Gordon Haskett
Gordon Haskett analyst John Inch started Honeywell with a Buy rating and $175 price target.
10/02/18
HSBC
10/02/18
DOWNGRADE
HSBC
Hold
Honeywell downgraded to Hold from Buy at HSBC

TODAY'S FREE FLY STORIES

APYX

Apyx Medical

$7.93

0.005 (0.06%)

13:25
03/18/19
03/18
13:25
03/18/19
13:25
Conference/Events
Apyx Medical management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

T

AT&T

$30.77

0.09 (0.29%)

13:24
03/18/19
03/18
13:24
03/18/19
13:24
Periodicals
Kevin Tsujihara ousted as Warner Bros. CEO, CNBC reports »

Kevin Tsujihara has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 24

    Apr

  • 26

    Apr

  • 20

    May

CXP

Columbia Property

$21.99

-0.13 (-0.59%)

13:21
03/18/19
03/18
13:21
03/18/19
13:21
Conference/Events
Columbia Property management to meet with JMP Securities »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

BSX

Boston Scientific

$37.77

-2.38 (-5.93%)

13:20
03/18/19
03/18
13:20
03/18/19
13:20
Options
Quarter million dollar block of calls sold to open in Boston Scientific »

Quarter million dollar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

  • 28

    May

MIK

Michaels

$11.72

0.04 (0.34%)

, DSW

DSW

$25.05

-0.34 (-1.34%)

13:19
03/18/19
03/18
13:19
03/18/19
13:19
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MIK

Michaels

$11.72

0.04 (0.34%)

DSW

DSW

$25.05

-0.34 (-1.34%)

HDS

HD Supply

$42.88

-0.12 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

REGN

Regeneron

$408.15

-6.03 (-1.46%)

, DERM

Dermira

$12.46

5.63 (82.43%)

13:17
03/18/19
03/18
13:17
03/18/19
13:17
On The Fly
Dermira rises, Regeneron slips on eczema treatment study results »

Shares of Dermira (DERM)…

REGN

Regeneron

$408.15

-6.03 (-1.46%)

DERM

Dermira

$12.46

5.63 (82.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 13

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
03/18/19
03/18
13:17
03/18/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
03/18/19
03/18
13:16
03/18/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBCP

Home Bancorp

$36.50

0.59 (1.64%)

13:14
03/18/19
03/18
13:14
03/18/19
13:14
Hot Stocks
Home Bancorp CEO John Bordelon sells over $232K shares of company stock »

Home Bancorp CEO John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$31.38

0.69 (2.25%)

13:14
03/18/19
03/18
13:14
03/18/19
13:14
Periodicals
Elanco tells Bloomberg CEO not planing to sell shares at lockup »

Elanco CEO Jeffrey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

APEN

Apollo Endosurgery

$3.29

-0.06 (-1.79%)

13:13
03/18/19
03/18
13:13
03/18/19
13:13
Recommendations
Apollo Endosurgery analyst commentary  »

Piper says Apollo's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 18

    May

  • 28

    May

QQQ

Invesco QQQ Trust

$178.07

0.1542 (0.09%)

13:10
03/18/19
03/18
13:10
03/18/19
13:10
Options
50K Invesco QQQ Jun 188 - 192 call spreads sold at 95c »

50K Invesco QQQ Jun 188 -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CARS

Cars.com

$22.75

0.04 (0.18%)

13:05
03/18/19
03/18
13:05
03/18/19
13:05
Options
Cars.com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:05
03/18/19
03/18
13:05
03/18/19
13:05
General news
FOMC Forecast revisions »

FOMC Forecast revisions…

AIR

AAR Corp.

$35.01

0.92 (2.70%)

13:01
03/18/19
03/18
13:01
03/18/19
13:01
Hot Stocks
AAR awarded $10.8M order from USAF to produce cargo pallets »

AAR has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

MYL

Mylan

$28.32

0.24 (0.85%)

12:51
03/18/19
03/18
12:51
03/18/19
12:51
Hot Stocks
Mylan Institutional LLC initiates voluntary recall of Levoleucovorin Injection »

Mylan Institutional LLC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTS

Ladenburg Thalmann

$2.99

0.03 (1.01%)

12:50
03/18/19
03/18
12:50
03/18/19
12:50
Recommendations
Ladenburg Thalmann analyst commentary at Barrington »

Ladenburg Thalmann price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$44.88

-0.19 (-0.42%)

12:49
03/18/19
03/18
12:49
03/18/19
12:49
Periodicals
Sanofi says working on plan to find new CEO, Reuters reports »

Sanofi is working on a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 28

    Apr

ATVI

Activision Blizzard

, SUI

Sun Communities

12:46
03/18/19
03/18
12:46
03/18/19
12:46
On The Fly
Fly Insider: Activision, Zebra among week's notable insider transactions »

Welcome to "Fly Insider,"…

ATVI

Activision Blizzard

SUI

Sun Communities

VRTX

Vertex

ESGR

Enstar Group

PBF

PBF Energy

OPK

Opko Health

$2.48

-0.035 (-1.39%)

CVS

CVS Health

FANG

Diamondback Energy

D

Dominion

SIX

Six Flags

BCO

Brink's

BK

BNY Mellon

PLNT

Planet Fitness

TNDM

TNDM

TTD

Trade Desk

AMH

American Homes 4 Rent

ZBRA

Zebra Technologies

ANSS

Ansys

IBP`

IBP Inc

COST

Costco

ZGNX

Zogenix

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 19

    Mar

  • 20

    Mar

  • 25

    Mar

  • 25

    Mar

  • 25

    Mar

  • 02

    Apr

  • 04

    Apr

  • 09

    Apr

  • 10

    Apr

  • 16

    Apr

  • 16

    Apr

  • 17

    Apr

  • 25

    Apr

  • 01

    May

  • 07

    May

  • 09

    May

  • 28

    May

  • 30

    May

ACA

Arcosa

$31.98

0.03 (0.09%)

12:46
03/18/19
03/18
12:46
03/18/19
12:46
Initiation
Arcosa initiated at Stephens »

Arcosa initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 19

    Mar

SEDG

SolarEdge

$39.40

-0.57 (-1.43%)

12:45
03/18/19
03/18
12:45
03/18/19
12:45
Recommendations
SolarEdge analyst commentary at Vertical Group »

SolarEdge lost second…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 20

    Mar

  • 21

    Mar

APHA

Aphria

$10.22

0.62 (6.46%)

12:45
03/18/19
03/18
12:45
03/18/19
12:45
Options
Aphria call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$202.24

3.97 (2.00%)

, SPGI

S&P Global

$205.03

1.91 (0.94%)

12:43
03/18/19
03/18
12:43
03/18/19
12:43
Hot Stocks
GSAM acquires S&P's Investment Advsisory Services; terms not disclosed »

Goldman Sachs Asset…

GS

Goldman Sachs

$202.24

3.97 (2.00%)

SPGI

S&P Global

$205.03

1.91 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$187.25

1.05 (0.56%)

12:36
03/18/19
03/18
12:36
03/18/19
12:36
Periodicals
Apple launches sixth developer beta of iOS 12.2, MacRumors reports »

Apple today plans to seed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMS

Scientific Games

$22.26

-0.67 (-2.92%)

12:35
03/18/19
03/18
12:35
03/18/19
12:35
Options
Scientific Games put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.